Pomerantz Law Firm Alerts Reckitt Benckiser Investors of Class Action Lawsuit Determined by Upcoming Deadline

Investor Alert: Pomerantz Law Firm's Notice on Reckitt Benckiser

On July 12, 2025, Pomerantz LLP announced a class action lawsuit against Reckitt Benckiser Group Plc (Reckitt). This notice serves to inform investors who have sustained losses in their investments related to Reckitt that they may be eligible to join the lawsuit. Individuals affected are encouraged to reach out to the firm to learn about their options and the steps required to participate.

Class Action Details

The lawsuit raises serious allegations against Reckitt and certain members of its leadership for purportedly engaging in securities fraud and other questionable business practices. Investors have until August 4, 2025, to petition the Court for the role of Lead Plaintiff if they purchased or otherwise acquired Reckitt securities during the specified class period. Interested parties can obtain a copy of the Complaint from Pomerantz Law.

Background of Legal Problems

An earlier locust point in this unfolding saga occurred on March 15, 2024, when an Illinois jury delivered a significant verdict of $60 million against Reckitt's subsidiary, Mead Johnson. The jury determined that Mead Johnson exhibited negligence by not adequately warning consumers that its cow's milk-based formula posed increased risks of necrotizing enterocolitis (NEC) for preterm infants. Following this news, Reckitt's American Depositary Share (ADS) saw a decline of $1.87
per share, marking a drop of nearly 14%, with shares closing at $11.44.

Subsequent developments escalated the company's legal challenges. On July 29, 2024, another jury in Missouri rendered a verdict of $495 million against Abbott Laboratories, illustrating similar concerns raised about Abbott's specialized baby formula's link to NEC. This ruling also adversely impacted Reckitt, causing a significant stock price drop of $1.02, closing at $10.64 per share.

These events depict a mounting legal headache for Reckitt, making the class action lawsuit particularly relevant to affected investors. As the company deals with these revelations, stakeholders are prompted to assess their options closely and determine whether they have grounds to participate in the ongoing litigation.

About Pomerantz LLP

Founded by the late Abraham L. Pomerantz, recognized as a pioneer in the area of class action litigation, Pomerantz LLP has built a robust reputation over 85 years for addressing the rights of shareholders against corporate misdeeds. This law firm has a long history of recovering substantial damages on behalf of those harmed by breaches of fiduciary duty and securities fraud. With expertise spanning various jurisdictions, including New York, Chicago, Los Angeles, London, Paris, and Tel Aviv, Pomerantz continues to engage in significant class actions.

As legal proceedings develop, those who believe they fit the criteria for participation in the Reckitt class action are urged to reach out to Pomerantz at 646-581-9980 or through their official email. Please provide your mailing address and other essential contact information when reaching out to facilitate communication. Investor awareness and actions taken before the impending deadline could significantly influence outcomes in these critical legal matters.